Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000480482) titled 'Drug allergy diagnostics, immunology, genomics (DALE) - A prospective registry and biorepository' on May 19.
Study Type: Observational
Study Design:
Purpose: Screening
Duration: Longitudinal
Selection: Defined population
Timing: Both
Primary Sponsor: The University of Melbourne
Condition:
Drug allergy
Drug allergy
Inflammatory and Immune System - Allergies
Intervention:
Patients with a reported drug allergy that have been reviewed clinically as an inpatient or outpatient at participating centres will be included in the registry through a waiver of consent, both retrospectively and prospectively. Demograp...